ViroPharma (Nasdaq: VPHM) reports Q2 earnings of $0.30 per share, above the consensus of $0.26 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE